Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

RXRX

Recursion Pharmaceuticals Inc

May 29 • 04:00PM ET

3.59

+0.15 4.36 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: RYTM KYMR NUVL BMRN MDGL INCY KRYS VKTX AXSM NBIX

| Held by: ARKK XBI VTI VB ARKG IWM VBK VXF IWO IBB

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.20	Insider Own	11.59%	Shs Outstand	524.46M	Perf Week	15.43%
Market Cap	1.91B	Forward P/E	-	EPS next Y	-0.87	Insider Trans	-2.42%	Shs Float	469.25M	Perf Month	8.79%
Enterprise Value	1.32B	PEG	-	EPS next Q	-0.24	Inst Own	59.14%	Short Float	39.31%	Perf Quarter	-2.18%
Income	-559.78M	P/S	28.69	EPS this Y	35.88%	Inst Trans	3.13%	Short Ratio	13.42	Perf Half Y	-17.85%
Sales	66.41M	P/B	1.86	EPS next Y	5.29%	ROA	-42.33%	Short Interest	184.44M	Perf YTD	-12.22%
Book/sh	1.93	P/C	2.89	EPS next 5Y	19.19%	ROE	-57.16%	52W High	7.18 -50.00%	Perf Year	-19.33%
Cash/sh	1.24	P/FCF	-	EPS past 3/5Y	-1.84% -22.39%	ROIC	-52.08%	52W Low	2.77 29.60%	Perf 3Y	-59.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	23.30% 79.91%	Gross Margin	-69.58%	Volatility	9.98% 7.04%	Perf 5Y	-86.38%
Dividend TTM	-	EV/Sales	19.84	EPS Y/Y TTM	32.35%	Oper. Margin	-881.32%	ATR (14)	0.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.47	Sales Y/Y TTM	11.07%	Profit Margin	-842.93%	RSI (14)	61.89	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.47	EPS Q/Q	55.84%	SMA20	12.68%	Beta	1.03	Target Price	6.64
Payout	-	Debt/Eq	0.07	Sales Q/Q	-56.11%	SMA50	9.36%	Rel Volume	2.13	Prev Close	3.44
Employees	600	LT Debt/Eq	0.05	Earnings	May 06 BMO	SMA200	-16.01%	Avg Volume	13.74M	Price	3.59
IPO	Apr 16, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.98% -60.06%	Trades		Volume	29,232,215	Change	4.36%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)